Literature DB >> 9525930

The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor.

H Yao1, R D York, A Misra-Press, D W Carr, P J Stork.   

Abstract

Induction of neuronal differentiation of the rat pheochromocytoma cell line, PC12 cells, by nerve growth factor (NGF) requires activation of the mitogen-activated protein (MAP) kinase or extracellular signal-regulated kinase (ERK). cAMP-dependent protein kinase (protein kinase A (PKA)) also can induce differentiation of these cells. Like NGF, the ability of PKA to differentiate PC12 cells is associated with a sustained activation of ERKs. Here we show that maximal sustained activation of ERK1 by NGF requires PKA. Inhibitors of PKA partially blocked activation of ERK1 by NGF but had no effect on activation of ERK1 by EGF. Inhibition of PKA also reduced the ability of NGF and cAMP, but not EGF, to activate the transcription factor Elk-1, reduced the induction of both immediate early and late genes after NGF treatment, and blocked the nuclear translocation of ERK1 induced by NGF. We propose that PKA is an important contributor to the activation of ERK1 by NGF and is required for maximal induction of gene expression by NGF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525930     DOI: 10.1074/jbc.273.14.8240

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Separate cyclic AMP sensors for neuritogenesis, growth arrest, and survival of neuroendocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Lee E Eiden
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

2.  Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Authors:  Tara C Tassin; David R Benavides; Florian Plattner; Akinori Nishi; James A Bibb
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

3.  cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Authors:  Ashley L Fritz; Maroof M Adil; Sunnie R Mao; David V Schaffer
Journal:  Mol Ther       Date:  2015-02-10       Impact factor: 11.454

4.  Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

Authors:  P D Deeble; D J Murphy; S J Parsons; M E Cox
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.

Authors:  O M Tsygankova; A Saavedra; J F Rebhun; L A Quilliam; J L Meinkoth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor.

Authors:  K Freeland; Y Z Liu; D S Latchman
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

7.  Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties.

Authors:  E Valjent; J C Corvol; C Pages; M J Besson; R Maldonado; J Caboche
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.

Authors:  J P Pursiheimo; M Jalkanen; K Taskén; P Jaakkola
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

9.  Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.

Authors:  J E Cavanaugh; J Ham; M Hetman; S Poser; C Yan; Z Xia
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

10.  The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation.

Authors:  Samantha Q Wales; Baiquan Li; Jennifer M Laing; Laure Aurelian
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.